SEARCH

SEARCH BY CITATION

References

  • Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2): S1S209.
  • Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, Calixto JB (2008). The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol 84: 12131221.
  • Calixto JB, Otuki MF, Santos AR (2003). Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B NF-kappaB). Planta Med 69: 973983.
  • Calixto JB, Campos MM, Otuki MF, Santos AR (2004). Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 70: 93103.
  • Corrêa P (1984). Dicionário de plantas úteis do Brasil e das Exóticas cultivadas. Imprensa Nacional: Rio de Janeiro.
  • Danese S, Sans M, De La Motte C, Graziani C, West G, Phillips MH et al. (2006). Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130: 20602073.
  • Davidson NJ, Fort MM, Muller W, Leach MW, Rennick DM (2000). Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response. Int Rev Immunol 19: 91121.
  • De Young LM, Kheifets JB, Ballaron SJ, Young JM (1989). Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions 26: 335341.
  • Fiorucci S, Orlandi S, Mencarelli A, Caliendo G, Santagada V, Distrutti E et al. (2007). Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol 150: 9961002.
  • Ghosh S, Karin M (2002). Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl.) S81S96.
  • Hara DB, Fernandes ES, Campos MM, Calixto JB (2007). Pharmacological and biochemical characterization of bradykinin B(2) receptors in the mouse colon: influence of the TNBS-induced colitis. Regul Pept 141: 2534.
  • Hara DB, Leite DF, Fernandes ES, Passos GF, Guimaraes AO, Pesquero JB et al. (2008). The relevance of kinin B1 receptor upregulation in a mouse model of colitis. Br J Pharmacol 154: 12761286.
  • Kweifio-Okai G, Bird D, Eu P, Carroll AR, Ambrose R, Field B (1994). Effect of alpha-amyrin palmitate on adjuvant arthritis. Drugs Exp Clin Res 20: 15.
  • McCafferty DM, Sihota E, Muscara M, Wallace JL, Sharkey KA, Kubes P (2000). Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 279: G90G99.
  • McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G (2008). Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 15: 100113.
  • Martin RA, Villegas I, La Casa C, & Alarcon de la Lastra, C (2003). The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol 481: 281291.
  • Medeiros R, Otuki MF, Avellar MC, Calixto JB (2007). Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Eur J Pharmacol 559: 227235.
  • Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL (1989). Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795803.
  • Neurath MF, Pettersson S (1997). Predominant role of NF-kappa B p65 in the pathogenesis of chronic intestinal inflammation. Immunobiology 198: 9198.
  • Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W (1995). Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182: 12811290.
  • OECD (2001). Guidelines for the Testing of Chemicals, OECD 420. Acute Oral Toxicity-Fixed Dose Procedure. Organisation for Economic Cooperation and Development: Paris.
  • Oliveira FA, Lima-Junior RC, Cordeiro WM, Vieira-Junior GM, Chaves MH, Almeida FR et al. (2004a). Pentacyclic triterpenoids, alpha,beta-amyrins, suppress the scratching behavior in a mouse model of pruritus. Pharmacol Biochem Behav 78: 719725.
  • Oliveira FA, Vieira-Junior GM, Chaves MH, Almeida FR, Santos KA, Martins FS et al. (2004b). Gastroprotective effect of the mixture of alpha- and beta-amyrin from Protium heptaphyllum: role of capsaicin-sensitive primary afferent neurons. Planta Med 70: 780782.
  • Oliveira FA, Chaves MH, Almeida FR, Lima RC Jr, Silva RM, Maia JL, et al. (2005). Protective effect of alpha- and beta-amyrin, a triterpene mixture from Protium heptaphyllum (Aubl.) March. trunk wood resin, against acetaminophen-induced liver injury in mice. J Ethnopharmacol 98: 103108.
  • Otuki MF, Ferreira J, Lima FV, Meyre-Silva C, Malheiros A, Muller LA et al. (2005a). Antinociceptive properties of mixture of alpha-amyrin and beta-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways. J Pharmacol Exp Ther 313: 310318.
  • Otuki MF, Vieira-Lima F, Malheiros A, Yunes RA, Calixto JB (2005b). Topical antiinflammatory effects of the ether extract from Protium kleinii and alpha-amyrin pentacyclic triterpene. Eur J Pharmacol 507: 253259.
  • Pham H, Chong B, Vincenti R, Slice LW (2008). Ang II and EGF synergistically induce COX-2 expression via CREB in intestinal epithelial cells. J Cell Physiol 214: 96109.
  • Recio MC, Giner RM, Manez S, Rios JL (1995). Structural requirements for the anti-inflammatory activity of natural triterpenoids. Planta Med 61: 182185.
  • Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T et al. (1998). Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 357369.
  • Rudiger AL, Siani AC, Veiga-Junior VF (2007). The chemistry and pharmacology of the South America genus Protium Burm. f. (Burseraceae). Phcog Rev 1: 93104.
  • Sakamoto C (1998). Roles of COX-1 and COX-2 in gastrointestinal pathophysiology. J Gastroenterol 33: 618624.
  • Sandor Z, Deng XM, Khomenko T, Tarnawski AS, Szabo S (2006). Altered angiogenic balance in ulcerative colitis: a key to impaired healing? Biochem Biophys Res Commun 350: 147150.
  • Sartor RB (2006). Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3: 390407.
  • Schroer K, Zhu Y, Saunders MA, Deng WG, Xu XM, Meyer-Kirchrath J et al. (2002). Obligatory role of cyclic adenosine monophosphate response element in cyclooxygenase-2 promoter induction and feedback regulation by inflammatory mediators. Circulation 105: 27602765.
  • Selve N, Wohrmann T (1992). Intestinal inflammation in TNBS sensitized rats as a model of chronic inflammatory bowel disease. Mediators Inflamm 1: 121126.
  • Siani AC, Ramos MF, Menezes-de-Lima O Jr, Ribeiro-dos-Santos R, Fernadez-Ferreira E, Soares RO et al. (1999). Evaluation of anti-inflammatory-related activity of essential oils from the leaves and resin of species of Protium. J Ethnopharmacol 66: 5769.
  • Tolstanova G, Khomenko T, Deng X, Chen L, Tarnawski A, Ahluwalia A et al. (2008). Neutralizing anti-VEGF antibody reduces severity of experimental ulcerative colitis in rats. Direct evidence for the pathogenic role of VEGF. J Pharmacol Exp Ther 328: 749757.
  • Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA (2008). Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig Liver Dis 40: 673679.
  • Do Vale AE, David JM, Brandao HN, David JP (2005). A new flavonol glycoside derivative from leaves of Moldenhawera nutans. Z Naturforsch [C] 60: 4549.
  • Wallace JL, MacNaughton WK, Morris GP, Beck PL (1989). Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96: 2936.
  • Zhao D (2007). Protein kinase Cdelta-mediated CREB activation regulates ghrelin-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colonic epithelial cells. J Cell Biochem 102: 12451255.